ARCT compared with NTLA: revenue, margins and what each company keeps, and the suppliers and customers both name

ARCTArcturus Therapeutics Holdings Inc.

Mkt capRevenueRevenue

NTLAIntellia Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

ARCTArcturus Therapeutics Holdings Inc.

NTLAIntellia Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closes · 500dMethod ›

Moved together

ARCTwithNTLA

×0.42co-movement · NTLA on ARCT · 500d

r 0.41scale to r 0.75

Shared co-movers4with ARCTwith NTLA

BEAMBeam Therapeutics Inc.r 0.45r 0.63

CRSPCRISPR Therapeutics AGr 0.43r 0.66

RXRXRecursion Pharmaceuticals, Inc.r 0.41r 0.52

RGNXRegenxbio Inc.r 0.39r 0.42

ARCT, solidNTLA, hatched× = co-movement · βr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

ARCTArcturus Therapeutics Holdings Inc.

9.39▼−13.61%

Mkt cap$309.0MRevenue$3MQ2 FY26Revenue$82MFY25

NTLAIntellia Therapeutics, Inc.

11.13▼−9.62%

Regular sessionNov 5 '26

Mkt cap$1.7BRevenue$8MQ2 FY26Revenue$68MFY25

Compare

Regular sessionNov 5 '26

ARCTArcturus Therapeutics Holdings Inc.

NTLAIntellia Therapeutics, Inc.

9.39▼−13.61%

Price

11.13▼−9.62%

$309.0M

Mkt cap

$1.7B

Q2 FY26$3M

Revenue

$8MQ2 FY26

FY25$82M

Revenue

$68MFY25

ARCT9.39▼−13.61%vsNTLA11.13▼−9.62%Regular sessionNov 5 '26